Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud against GPGI, Inc.

MILWAUKEE, July 21, 2026 (GLOBE NEWSWIRE) -- Ademi LLP is investigating possible securities fraud claims against GPGI (NYSE: GPGI). The investigation results from inaccurate statements GPGI may have made regarding its financial statements, business operations and prospects.

The investigation focuses on recent allegation regarding disclosures GPGI has been making with respect to its acquisition of Husky Technologies Limited.

Click here to join our investigation or to obtain additional information, or contact us at [email protected] or toll-free: 866-264-3995. There is no cost or obligation to you.

We specialize in securities fraud and shareholder litigation. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:
Ademi LLP
Guri Ademi
3620 East Layton Ave.
Cudahy, WI 53110
Toll Free: (866) 264-3995
Fax: (414) 482-8001
www.ademilaw.com

You May Also Be Interested In

• Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development
• [Ad hoc announcement pursuant to Art. 53 LR] Roche’s strong momentum continues in the first half of 2026, delivering +6% sales growth at constant exchange rates; -2% in CHF due to the significant ap
• Medidata Launches Medidata Plus, an AI-Native Foundation Built to Scale Clinical Portfolios